Skip to main content

Schwab Andrew J.'s Form 4 filing

Skye Bioscience, Inc. (SKYE) · filed Aug 20, 2026

Accession no.
0001598549-26-000005
Filed
Aug 20, 2026, 5:59 PM ET
Trade date
Aug 18-20, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $140.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schwab Andrew J.CIK 0001598549Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2026Common StockSSaleDisposed−45,090$0.38−$17,134.21,411,974IndirectDuplicate filing
Aug 18, 2026Common StockSSaleDisposed−1,830$0.38−$695.455,663IndirectDuplicate filing
Aug 18, 2026Common StockSSaleDisposed−253,080$0.38−$96,170.47,914,126IndirectDuplicate filing
Aug 19, 2026Common StockSSaleDisposed−10,255$0.35−$3,589.251,401,719IndirectDuplicate filing
Aug 19, 2026Common StockSSaleDisposed−409$0.35−$143.1555,254IndirectDuplicate filing
Aug 19, 2026Common StockSSaleDisposed−57,476$0.35−$20,116.67,856,650IndirectDuplicate filing
Aug 20, 2026Common StockSSaleDisposed−1,159$0.32−$370.881,400,560IndirectDuplicate filing
Aug 20, 2026Common StockSSaleDisposed−46$0.32−$14.7255,208IndirectDuplicate filing
Aug 20, 2026Common StockSSaleDisposed−6,495$0.32−$2,078.47,850,155IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)